indocyanine green has been researched along with Schizophrenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audo, I; Faure, C; Letessier, JB; Robert, MP; Zeitz, C | 1 |
| Badurski, J; Makosa, M; Sarosiek, J; Tolwiński, T | 1 |
2 other study(ies) available for indocyanine green and Schizophrenia
| Article | Year |
|---|---|
Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.
Topics: Antipsychotic Agents; Aripiprazole; Coloring Agents; Dark Adaptation; Electrooculography; Electroretinography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Multimodal Imaging; Piperazines; Quinolones; Retina; Retinal Diseases; Retinal Pigment Epithelium; Schizophrenia; Tomography, Optical Coherence; Visual Acuity | 2015 |
[Use of indocyanine green in the assessment of liver function in schizophrenics].
Topics: Adult; Antipsychotic Agents; Female; Humans; Indocyanine Green; Liver; Male; Middle Aged; Phenothiazines; Schizophrenia; Transaminases | 1973 |